tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Palvella Therapeutics (PVLA) Similar Stocks

Compare
696 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$91.91
$1.18B
-7.91
727.63%
15 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$18.79
$952.13M
33.40
95.93%
4 Buy
1 Hold
0 Sell
Strong Buy
Monopar Therapeutics Inc
$68.63
$458.63M
-19.96
188.48%
12 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$18.52
$1.88B
-6.24
-6.61%
14 Buy
2 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$39.90
$4.24B
-38.66
580.89%
10 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$25.51
$1.36B
-13.57
82.21%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PVLA
Palvella Therapeutics
99.73
87.73
731.08%
TBPH
Theravance Biopharma
18.79
9.00
91.93%
MNPR
Monopar Therapeutics Inc
68.63
44.63
185.96%
NRIX
Nurix Therapeutics
18.52
-1.46
-7.31%
TERN
Terns Pharmaceuticals
39.90
33.97
572.85%
TYRA
Tyra Bioscience
25.51
11.26
79.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts